Clinical trial recruitment platform Trially has raised $4.7m in a seed funding round and introduced its agentic AI solution, Margo, designed to increase study enrolment by converting patient matches into actual subjects. The company said that 86% of trials experience delays due to recruitment issues, resulting in the pharma industry incurring significant losses daily, while patients endure lengthy waits for potentially life-saving treatments. As the first fully integrated AI platform designed to address ...